PLMR:NASDAQPalomar Holdings, Inc. Analysis
Data as of 2026-06-03 - not real-time
$102.28
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Palomar Holdings (PLMR) is trading at $102.28, far beneath its DCF‑derived fair value of $711 and the median analyst target of $156, suggesting a sizable upside. The stock shows an RSI of 28, indicating oversold conditions, while the 20‑day SMA (≈$110.6) sits above the current price, confirming short‑term bearish pressure. Despite a bearish MACD and decreasing volume, the company posted a 59.7% revenue surge YoY, a robust operating margin of 20.3%, and a forward EPS growth trajectory that lifts the forward PE to just 9.1. The balance sheet reflects modest leverage (debt‑to‑equity ~31) and a low beta of 0.31, but volatility remains high at ~32% over 30 days, and the max drawdown exceeds 40%.
Recent earnings beats, an expanded product line via the Gray Surety acquisition, and a newly announced buyback program reinforce the fundamental narrative. With no dividend, the focus remains on earnings reinvestment and growth. Overall, the technical downside appears temporary against a backdrop of strong profitability, attractive valuation gaps, and a clear upside potential.
Recent earnings beats, an expanded product line via the Gray Surety acquisition, and a newly announced buyback program reinforce the fundamental narrative. With no dividend, the focus remains on earnings reinvestment and growth. Overall, the technical downside appears temporary against a backdrop of strong profitability, attractive valuation gaps, and a clear upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI suggesting potential rebound
- Current price near key support at $100.81
- Bearish MACD and decreasing volume indicating short‑term pressure
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside versus DCF and analyst targets
- Strong revenue and EPS growth with expanding specialty lines
- Buyback announcement and recent earnings beat boosting confidence
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable profitability (ROE ~22.5%) and low beta
- Strategic acquisition diversifying catastrophe exposure
- Long‑term valuation gap and resilient cash flow generation
Key Metrics & Analysis
Financial Health
Revenue Growth59.70%
Profit Margin20.11%
P/E Ratio14.3
ROE22.53%
ROA5.31%
Debt/Equity31.01
P/B Ratio2.8
Op. Cash Flow$369.0M
Free Cash Flow$528.4M
Industry P/E16.5
Technical Analysis
TrendBearish
RSI28.1
Support$100.81
Resistance$118.27
MA 20$110.61
MA 50$119.08
MA 200$121.88
MACDBearish
VolumeDecreasing
Fear & Greed Index92.84
Valuation
Fair Value$711.02
Target Price$154.17
Upside/Downside50.74%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.31
Volatility31.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.